Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Selectis Health (GBCS) Revenue (2017 - 2025)

Selectis Health's Revenue history spans 14 years, with the latest figure at $10.8 million for Q3 2025.

  • For Q3 2025, Revenue rose 8.22% year-over-year to $10.8 million; the TTM value through Sep 2025 reached $42.2 million, up 10.1%, while the annual FY2024 figure was $39.5 million, 7.36% up from the prior year.
  • Revenue for Q3 2025 was $10.8 million at Selectis Health, up from $10.4 million in the prior quarter.
  • Across five years, Revenue topped out at $11.5 million in Q2 2022 and bottomed at $5.8 million in Q1 2021.
  • The 5-year median for Revenue is $9.6 million (2023), against an average of $9.4 million.
  • The largest annual shift saw Revenue soared 90.71% in 2022 before it decreased 22.13% in 2023.
  • A 5-year view of Revenue shows it stood at $10.2 million in 2021, then rose by 5.95% to $10.8 million in 2022, then decreased by 14.78% to $9.2 million in 2023, then grew by 12.99% to $10.4 million in 2024, then grew by 4.25% to $10.8 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Revenue are $10.8 million (Q3 2025), $10.4 million (Q2 2025), and $10.5 million (Q1 2025).